Testing

View a list of updates that were posted to MayoMedicalLaboratories.com during the month of June 2017.

By Rene Revier • July 25, 2017

Newborn screening tests for a variety of conditions are available in every state, however, test performance and response rate by each state is very different. Mayo Clinic’s Biochemical Genetics Laboratory created the Collaborative Laboratory Integrated Reports tool to mitigate the national (and international) problem of false positives and to raise the bar on test performance.

By Christophe Bahn • July 24, 2017
Image for Hereditary Peripheral Neuropathy webinar

Wednesday, August 9 | 11 a.m.–noon CT
An educational overview of the large category of peripheral neuropathies, discussing various testing platforms strengths and weaknesses, with a focus on identifying hereditary neuropathies.

By MML Education • July 12, 2017

Dietrich Matern, M.D., Ph.D., discusses the importance of newborn screening, the conditions included within the Recommended Universal Screening Panel, and the new newborn screening panels available through Mayo Medical Laboratories.

By Mayo Medical Laboratories • July 10, 2017

Wednesday, August 30 | Noon–1 p.m. CT
This presentation offers an educational overview of next-generation sequencing (NGS) testing for hematologic malignancies, specifically myeloid disorders and multiple myeloma.

By MML Education • July 6, 2017

The following list of updates were posted to MayoMedicalLaboratories.com during the month of May 2017.

By Rene Revier • June 26, 2017

Originally Presented June 12, 2017
This presentation offers an educational overview of autoimmune central nervous system disorders, evaluations (including antibody testing), and treatments.

By Mayo Medical Laboratories • June 22, 2017

In May 2017, Mayo Medical Laboratories announced eight brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • June 8, 2017

The following list of updates were posted to MayoMedicalLaboratories.com during the month of April 2017: CPT […]

By Rene Revier • May 25, 2017

Mayo Clinic has launched a first-of-its-kind clinical test that will be used to help patients who may be at a diagnostic “dead end” with other genetic testing. The mate-pair sequencing test can identify chromosome alterations or “breakpoints” involved in chromosome rearrangements, pinpointing the precise genes involved.

By Gina Chiri-Osmond • May 12, 2017

Clinical Laboratory News recently highlighted a Mayo Clinic study that shows how plasma ceramides may predict cardiovascular events in patients with or without coronary artery disease.

By Kelley Schreiber • May 12, 2017

In April 2017, Mayo Medical Laboratories announced five brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • May 11, 2017

Useful For Assessing the patient’s probability of having detectable prostate cancer when total prostate specific […]

By Mayo Medical Laboratories • May 9, 2017